News for Algernon Pharmaceuticals Inc. (AGNPF)

Clearmind Medicine (CMND) has officially initiated its U.S. clinical trial site at Yale School of Medicine, marking a significant milestone in its Phase I/IIa t

Clearmind Medicine (CMND) has embarked on a significant venture in its journey towards innovative addiction treatments by initiating a Phase I/IIa clinical tria

**media[588934]**

VANCOUVER, British Columbia, April 08, 2025 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AG…

**media[537494]**

**media[532711]**

VANCOUVER, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGN…

VANCOUVER, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the ”œCompany” or ”œAlgernon”) (CSE: AGN) (FRANKFURT: AGW0

VANCOUVER, British Columbia, July 31, 2024 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “

VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon…

WAVERLEY PHARMA INC. MANAGEMENT PROXY CIRCULAR and NOTICE OF ANNUAL AND SPECIAL MEETING May 2,...

VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0)…

Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position

VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0)…

The psychedelics space is up and running. Together with the start of the new year, two companies have shared their latest financial decisions toward advancing their medical business programs.

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...

VANCOUVER, British Columbia, Sept. 09, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or…

New York, March 03, 2021 (GLOBE NEWSWIRE) -- - Medexus Pharmaceuticals Inc (CVE:MDP)  shares climb as Canaccord Genuity upgrades rating to Buy from Hold ...